Critical Care Therapies Associated with Long-term Outcomes After Acute Lung Injur
与急性肺损伤后长期结果相关的重症监护治疗
基本信息
- 批准号:8076812
- 负责人:
- 金额:$ 13.29万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-07-01 至 2015-06-30
- 项目状态:已结题
- 来源:
- 关键词:AcuteAcute Lung InjuryAnxietyAreaAwardBiometryBlood TransfusionCaringClinical InvestigatorClinical ResearchCohort StudiesCommunicationCritical CareCritical IllnessData AnalysesData CollectionDecision MakingDevelopmentDevelopment PlansEducational CurriculumEpidemiologyFamilyFamily memberFundingFutureGoalsHealth Services ResearchHypoglycemiaIntensive Care UnitsInterventionLeadLightLungMedical RecordsMental DepressionMental HealthMentored Patient-Oriented Research Career Development AwardMentorsMorbidity - disease rateOutcomeOutcome AssessmentPathway interactionsPatient CarePatientsPhysiciansPost-Traumatic Stress DisordersPublishingQualitative MethodsQuality of lifeResearchResearch Project GrantsResearch ProposalsRisk FactorsRoleScientistSedation procedureStatistical MethodsSurveysSurvivorsSymptomsSyndromeUnited Statesabstractingadverse outcomebasecareercareer developmentdesignexperiencefunctional outcomesfunctional statushealth related quality of lifehigh riskimprovedinnovationloved onesnovelpatient oriented researchprospectivepsychologicpsychological distresspsychological outcomespublic health relevanceskillssuccesssuccessful interventionsymposiumtheoriestherapy developmenttherapy outcome
项目摘要
DESCRIPTION (provided by applicant): This K-23 award will provide an opportunity for Dr. Kross to become an independent physician scientist focused on improving long-term outcomes for patients with acute lung injury. Through her patient-oriented research proposal, Dr. Kross will identify modifiable critical care risk factors for psychological and functional morbidity among patients with acute lung injury and their family members. Importantly, in order to develop innovative approaches for intervention, she will also evaluate a novel hypothesis of psychological and functional morbidity shared between patients experiencing critical illness and critical care therapies and their families. With the goal of developing a career studying therapies and outcomes for patients with acute lung injury, as well as their families, Dr. Kross proposes an integrated curriculum consisting of practical experience in designing, conducting and publishing clinical research projects; coursework in epidemiology, biostatistics and health services research; and intensive mentoring by experts in the psychological and functional outcomes of critical illness. Dr. Kross will use this K23 award to become an independently funded clinical investigator with skills in the design and conduct of clinical studies of patients with acute lung injury and their families. Moreover, she will develop expertise in survey-based outcome assessment, standardized medical record abstraction, clustered and longitudinal statistical methods, and qualitative data collection and analysis. This career development plan will lead to a successful and independent research career focused on understanding and improving long-term outcomes of acute lung injury. To achieve these goals Dr. Kross will conduct a prospective cohort study to: 1) identify associations between modifiable critical care predictors of psychological and functional morbidity for patients with acute lung injury; 2) identify associations between modifiable critical care predictors of psychological and functional morbidity for families of patients of acute lung injury; 3) identify associations between psychological and functional morbidity for patients surviving acute lung injury and psychological and functional morbidity for their families; and 4) use qualitative methods to explore potential critical care approaches to interventions that will improve long-term outcomes for patients and their families. This project has important implications for patients with acute lung injury and their families. The identification of modifiable critical care risk factors for long-term psychological symptoms and decreased functional status for both patients with acute lung injury and their families will inform the development of future critical care interventions to reduce these consequences of acute lung injury.
PUBLIC HEALTH RELEVANCE:
Acute lung injury is a common syndrome of critical illness in the United States. While morbidity is high, the majority of patients with acute lung injury will survive their illness, and, therefore, the long-term consequences of this illness become important. This project has the goal of better understanding the risk factors for long-term psychological symptoms and decreased quality of life among patients with acute lung injury and their family members, and informing the development of interventions that will decrease psychological symptoms and improve quality of life of patients with acute lung injury and their families. (End of Abstract)
描述(由申请人提供):这个K-23奖项将为Kross博士提供一个机会,使他成为一名独立的内科科学家,专注于改善急性肺损伤患者的长期结果。通过她的以病人为中心的研究方案,Kross博士将确定急性肺损伤患者及其家人心理和功能发病率的可改变的危重护理风险因素。重要的是,为了开发干预的创新方法,她还将评估一种新的假说,即经历危重疾病和危重护理治疗的患者及其家人之间共享的心理和功能发病率。为了发展为急性肺损伤患者及其家人研究治疗方法和结果的职业生涯,Kross博士提出了一项综合课程,包括设计、实施和发表临床研究项目的实践经验;流行病学、生物统计学和卫生服务研究的课程;以及由专家进行的关于危重疾病的心理和功能结果的密集指导。Kross博士将利用这一K23奖项成为一名独立资助的临床研究员,拥有设计和实施急性肺损伤患者及其家人的临床研究的技能。此外,她还将发展以调查为基础的结果评估、标准化病历摘要、集群和纵向统计方法以及定性数据收集和分析方面的专业知识。这一职业发展计划将导致一个成功和独立的研究职业生涯,重点是了解和改善急性肺损伤的长期结果。为了实现这些目标,Kross博士将进行一项前瞻性队列研究,以:1)确定急性肺损伤患者心理和功能发病率的可调性重症监护预测指标之间的关联;2)确定急性肺损伤患者家属心理和功能发病率的可调性危重预测指标之间的关联;3)确定急性肺损伤存活者的心理和功能发病率与其家人的心理和功能发病率之间的关联;以及4)使用定性方法探索潜在的危重病护理干预方法,以改善患者及其家人的长期结局。本项目对急性肺损伤患者及其家属具有重要意义。为急性肺损伤患者及其家属的长期心理症状和功能状态下降确定可改变的重症监护危险因素,将有助于未来重症监护干预措施的发展,以减少急性肺损伤的这些后果。
公共卫生相关性:
在美国,急性肺损伤是一种常见的危重病综合征。虽然发病率很高,但大多数急性肺损伤患者都能存活下来,因此,这种疾病的长期后果变得重要。该项目的目标是更好地了解急性肺损伤患者及其家人出现长期心理症状和生活质量下降的危险因素,并为制定干预措施提供信息,这些干预措施将减轻急性肺损伤患者及其家人的心理症状,提高其生活质量。(摘要结束)
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Erin Kathryn Kross其他文献
Erin Kathryn Kross的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Erin Kathryn Kross', 18)}}的其他基金
Predictors of resilience and positive outcomes for patients with acute respiratory failure and their family members: an observational study to guide intervention development
急性呼吸衰竭患者及其家人的恢复力和积极结果的预测因素:指导干预措施开发的观察性研究
- 批准号:
9279238 - 财政年份:2016
- 资助金额:
$ 13.29万 - 项目类别:
Critical Care Therapies Associated with Longterm Outcomes After Acute Lung Injury
与急性肺损伤后长期结果相关的重症监护治疗
- 批准号:
8500428 - 财政年份:2010
- 资助金额:
$ 13.29万 - 项目类别:
Critical Care Therapies Associated with Longterm Outcomes After Acute Lung Injury
与急性肺损伤后长期结果相关的重症监护治疗
- 批准号:
8286930 - 财政年份:2010
- 资助金额:
$ 13.29万 - 项目类别:
Critical Care Therapies Associated with Long-term Outcomes After Acute Lung Injur
与急性肺损伤后长期结果相关的重症监护治疗
- 批准号:
7771276 - 财政年份:2010
- 资助金额:
$ 13.29万 - 项目类别:
Critical Care Therapies Associated with Longterm Outcomes After Acute Lung Injury
与急性肺损伤后长期结果相关的重症监护治疗
- 批准号:
8683215 - 财政年份:2010
- 资助金额:
$ 13.29万 - 项目类别:
Critical care therapies associated with longterm outcomes after acute lung injury
与急性肺损伤后长期结局相关的重症监护治疗
- 批准号:
7745778 - 财政年份:2009
- 资助金额:
$ 13.29万 - 项目类别:
相似海外基金
Combinatorial cytokine-coated macrophages for targeted immunomodulation in acute lung injury
组合细胞因子包被的巨噬细胞用于急性肺损伤的靶向免疫调节
- 批准号:
10648387 - 财政年份:2023
- 资助金额:
$ 13.29万 - 项目类别:
Lung epithelial cell-derived C3 in acute lung injury
肺上皮细胞衍生的 C3 在急性肺损伤中的作用
- 批准号:
10720687 - 财政年份:2023
- 资助金额:
$ 13.29万 - 项目类别:
Examining the role of TRMT1 and tRNA methylation in acute lung injury and ARDS
检查 TRMT1 和 tRNA 甲基化在急性肺损伤和 ARDS 中的作用
- 批准号:
10719249 - 财政年份:2023
- 资助金额:
$ 13.29万 - 项目类别:
Inducible HMGB1 antagonist for viral-induced acute lung injury.
诱导型 HMGB1 拮抗剂,用于治疗病毒引起的急性肺损伤。
- 批准号:
10591804 - 财政年份:2023
- 资助金额:
$ 13.29万 - 项目类别:
MAP2K1 AND MAP2K2 IN ACUTE LUNG INJURY AND RESOLUTION
MAP2K1 和 MAP2K2 在急性肺损伤中的作用及缓解
- 批准号:
10741574 - 财政年份:2023
- 资助金额:
$ 13.29万 - 项目类别:
Development of a new treatment for COVID-19-related acute lung injury targeting the microbiota-derived peptide corisin
针对微生物群衍生肽 corisin 开发治疗 COVID-19 相关急性肺损伤的新疗法
- 批准号:
23K07651 - 财政年份:2023
- 资助金额:
$ 13.29万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Probing immunovascular mechanobiology in pneumonia-associated acute lung injury at the single capillary level
在单毛细血管水平探讨肺炎相关急性肺损伤的免疫血管力学生物学
- 批准号:
10679944 - 财政年份:2023
- 资助金额:
$ 13.29万 - 项目类别:
The amyloid precursor protein protects against acute lung injury
淀粉样前体蛋白可预防急性肺损伤
- 批准号:
10575258 - 财政年份:2023
- 资助金额:
$ 13.29万 - 项目类别:
Role of macrophages and miRNA in regulating lung macrophage polarization and lung pathogenesis during respiratory virus-induced acute lung injury in normal and diabetic Syrian hamsters.
正常和糖尿病叙利亚仓鼠呼吸道病毒引起的急性肺损伤期间巨噬细胞和 miRNA 在调节肺巨噬细胞极化和肺部发病机制中的作用。
- 批准号:
10701207 - 财政年份:2023
- 资助金额:
$ 13.29万 - 项目类别:
Roles of N-glycans on neutrophil beta2 integrins in progression of acute lung injury
N-聚糖对中性粒细胞β2整合素在急性肺损伤进展中的作用
- 批准号:
10837431 - 财政年份:2023
- 资助金额:
$ 13.29万 - 项目类别: